FTC sues main pharmacy benefit administrators above insulin costs The company introduced motion towards Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the record cost of daily life-preserving insulin medications. Elevance lowers guidance on ‘unprecedented’ Medicaid issues Executives claimed the amplified f... https://daveshotchickencalories49493.blogzag.com/74825088/healthcare-news-an-overview